Health-related quality of life after treatment for bladder cancer in England
Background Little is known about quality of life after bladder cancer treatment. This common cancer is managed using treatments that can affect urinary, sexual and bowel function. Methods To understand quality of life and inform future care, the Department of Health (England) surveyed adult...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Cancer Research UK
2018
|
| Online Access: | https://eprints.nottingham.ac.uk/51974/ |
| _version_ | 1848798617124470784 |
|---|---|
| author | Mason, Samantha J. Downing, Amy Wright, Penny Hounsome, Luke Bottomley, Sarah E. Corner, Jessica Richards, Mike Catto, James W. Glaser, Adam W. |
| author_facet | Mason, Samantha J. Downing, Amy Wright, Penny Hounsome, Luke Bottomley, Sarah E. Corner, Jessica Richards, Mike Catto, James W. Glaser, Adam W. |
| author_sort | Mason, Samantha J. |
| building | Nottingham Research Data Repository |
| collection | Online Access |
| description | Background
Little is known about quality of life after bladder cancer treatment. This common cancer is managed using treatments that can affect urinary, sexual and bowel function.
Methods
To understand quality of life and inform future care, the Department of Health (England) surveyed adults surviving bladder cancer 1–5 years after diagnosis. Questions related to disease status, co-existing conditions, generic health (EQ-5D), cancer-generic (Social Difficulties Inventory) and cancer-specific outcomes (Functional Assessment of Cancer Therapy—Bladder).
Results
In total, 673 (54%) patients responded; including 500 (74%) men and 539 (80%) with co-existing conditions. Most respondents received endoscopic treatment (60%), while 92 (14%) and 99 (15%) received radical cystectomy or radiotherapy, respectively. Questionnaire completion rates varied (51–97%). Treatment groups reported ≥1 problem using EQ-5D generic domains (59–74%). Usual activities was the most common concern. Urinary frequency was common after endoscopy (34–37%) and radiotherapy (44–50%). Certain populations were more likely to report generic, cancer-generic and cancer-specific problems; notably those with co-existing long-term conditions and those treated with radiotherapy.
Conclusion
The study demonstrates the importance of assessing patient-reported outcomes in this population. There is a need for larger, more in-depth studies to fully understand the challenges patients with bladder cancer face. |
| first_indexed | 2025-11-14T20:22:37Z |
| format | Article |
| id | nottingham-51974 |
| institution | University of Nottingham Malaysia Campus |
| institution_category | Local University |
| last_indexed | 2025-11-14T20:22:37Z |
| publishDate | 2018 |
| publisher | Cancer Research UK |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | nottingham-519742020-05-04T19:36:20Z https://eprints.nottingham.ac.uk/51974/ Health-related quality of life after treatment for bladder cancer in England Mason, Samantha J. Downing, Amy Wright, Penny Hounsome, Luke Bottomley, Sarah E. Corner, Jessica Richards, Mike Catto, James W. Glaser, Adam W. Background Little is known about quality of life after bladder cancer treatment. This common cancer is managed using treatments that can affect urinary, sexual and bowel function. Methods To understand quality of life and inform future care, the Department of Health (England) surveyed adults surviving bladder cancer 1–5 years after diagnosis. Questions related to disease status, co-existing conditions, generic health (EQ-5D), cancer-generic (Social Difficulties Inventory) and cancer-specific outcomes (Functional Assessment of Cancer Therapy—Bladder). Results In total, 673 (54%) patients responded; including 500 (74%) men and 539 (80%) with co-existing conditions. Most respondents received endoscopic treatment (60%), while 92 (14%) and 99 (15%) received radical cystectomy or radiotherapy, respectively. Questionnaire completion rates varied (51–97%). Treatment groups reported ≥1 problem using EQ-5D generic domains (59–74%). Usual activities was the most common concern. Urinary frequency was common after endoscopy (34–37%) and radiotherapy (44–50%). Certain populations were more likely to report generic, cancer-generic and cancer-specific problems; notably those with co-existing long-term conditions and those treated with radiotherapy. Conclusion The study demonstrates the importance of assessing patient-reported outcomes in this population. There is a need for larger, more in-depth studies to fully understand the challenges patients with bladder cancer face. Cancer Research UK 2018-05-14 Article PeerReviewed Mason, Samantha J., Downing, Amy, Wright, Penny, Hounsome, Luke, Bottomley, Sarah E., Corner, Jessica, Richards, Mike, Catto, James W. and Glaser, Adam W. (2018) Health-related quality of life after treatment for bladder cancer in England. British Journal of Cancer, 118 (11). pp. 1518-1528. ISSN 1532-1827 https://doi.org/10.1038/s41416-018-0084-z doi:10.1038/s41416-018-0084-z doi:10.1038/s41416-018-0084-z |
| spellingShingle | Mason, Samantha J. Downing, Amy Wright, Penny Hounsome, Luke Bottomley, Sarah E. Corner, Jessica Richards, Mike Catto, James W. Glaser, Adam W. Health-related quality of life after treatment for bladder cancer in England |
| title | Health-related quality of life after treatment for bladder cancer in England |
| title_full | Health-related quality of life after treatment for bladder cancer in England |
| title_fullStr | Health-related quality of life after treatment for bladder cancer in England |
| title_full_unstemmed | Health-related quality of life after treatment for bladder cancer in England |
| title_short | Health-related quality of life after treatment for bladder cancer in England |
| title_sort | health-related quality of life after treatment for bladder cancer in england |
| url | https://eprints.nottingham.ac.uk/51974/ https://eprints.nottingham.ac.uk/51974/ https://eprints.nottingham.ac.uk/51974/ |